Sort
326,823 grants matching “clinical trial”
Administrative Core
$1,709,518Deborah J Goff · Dana-Farber Cancer Inst · P30 · FY2023 · CA
LAAZ-NPH Clinical Center
$1,709,511Eric Ravussin · Lsu Pennington Biomedical Research Ctr · UG1 · FY2023 · HD
Administrative Core
$1,709,477Deborah J Goff · Dana-Farber Cancer Inst · P30 · FY2022 · CA
Translational Research in Breast Cancer
$1,709,045Xiang Zhang · Baylor College Of Medicine · P50 · FY2024 · CA
1/2 Genetics at an extreme: an efficient genomic study of individuals with clinically severe major depression receiving ECT
$1,708,908Peter P Zandi · Johns Hopkins University · R01 · FY2020 · MH
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$1,708,836Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2018 · AG
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.
$1,708,787Dart Clint · Health Decisions, Inc. · N01 · FY2022 · HD
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,708,776Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$1,708,646Linmarie Sikich · Duke University · U01 · FY2016 · HD
Genome-wide case-only study of antihypertensive drug-gene interactions
$1,708,531Bruce M Psaty · University Of Washington · R01 · FY2010 · HL
Targeted Long-acting Combination Antiretroviral Therapy (TLC-ART)
$1,708,470Rodney J.y. Ho · University Of Washington · UM1 · FY2019 · AI
Towards Eradication: Reducing Proviral HIV DNA with Interferon-a Immunotherapy
$1,708,367Luis J. Montaner · Wistar Institute · U01 · FY2014 · AI
Preclinical development of myosolvins, a new class of medicine for asthma
$1,708,130Julian Solway · University Of Chicago · UH3 · FY2016 · HL
Oral Fluid NanoSensor Test (OFNASET)
$1,707,866David T Wong · University Of California Los Angeles · U01 · FY2007 · DE
CombinADO: a combination intervention strategy to improve health outcomes for adolescents living with HIV
$1,707,601Elaine Janine Abrams · Columbia University Health Sciences · UH3 · FY2021 · HD
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder
$1,707,595Boris Tabakoff · Lohocla Research Corporation · R44 · FY2025 · AA
Peruvian/Brazilian Amazon Center of Excellence in Malaria
$1,707,573Joseph M. Vinetz · University Of California, San Diego · U19 · FY2012 · AI
Improving HbF induction by inhibiting epigenetic target enzymes
$1,707,550James Douglas Engel · University Of Michigan At Ann Arbor · U01 · FY2014 · HL
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
$1,707,517Meredith Hay · University Of Arizona · U01 · FY2024 · AG
TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29
$1,707,498Eve Jelstrom · The Emmes Company, Llc · N01 · FY2025 · DA
1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD
$1,707,493Nadia N Hansel · Johns Hopkins University · UH3 · FY2025 · HL
PACT
$1,707,472Jason Jacobs · University Of Minnesota · N01 · FY2012 · HL
(HVTN) HIV VACCINE TRIAL UNITS
$1,707,451Johns Hopkins University · U01 · FY2002 · AI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,707,387William W Hauswirth · University Of Florida · R24 · FY2014 · EY
Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies
$1,707,308Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI